|
|||||
|
|
||||||
J Clin Oncol Locker et al. 24:5313 Publisher's NoteImportant note: The recommendations for KRAS use in patients with metastatic colorectal cancer who are candidates for anti-EGFR antibody therapy have been updated since the publication of this guideline. The new recommendations are now reflected in a Provisional Clinical Opinion (PCO) on KRAS Testing.
|
||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||
|
Copyright © 2009 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|